Invasive Mechanical Ventilation in Chronic Obstructive Pulmonary Disease Exacerbations

Abstract

Chronic obstructive pulmonary disease (COPD) continues to be an important cause of morbidity, mortality, and health care costs worldwide. Although there exist some heterogeneity between patients, the course of COPD is characterized by recurrent acute exacerbations, which are among the most common causes of medical admission to hospital. Patients with frequent exacerbations have accelerated lung function decline, worse quality of life, and greater mortality. Therefore, interest is growing in assessing the effectiveness of interventions used to treat exacerbations. The present review summarizes the current evidence regarding the use of ventilatory management to treat COPD and the implementation of novel cost-effective strategies, such as high-flow oxygenation or extracorporeal carbon dioxide removal to improve clinical outcomes and functional recovery in this disease and to reduce the associated costs.

Keywords

chronic obstructive pulmonary disease - exacerbation - mechanical ventilation

Publikationsverlauf

Artikel online veröffentlicht:
03. August 2020

• References

• 1 GOLD. 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD. Available at: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/ . Accessed August 2, 2019
• 2 Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet 2017; 389 (10082): 1931-1940
• 3 Agustí AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2 (04) 367-370 , discussion 371–372
• 4 Curkendall SM, Lanes S, de Luise C. et al. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur J Epidemiol 2006; 21 (11) 803-813
• 5 Di Marco F, Verga M, Reggente M. et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006; 100 (10) 1767-1774
• 6 Mallia P, Johnston SL. Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc 2005; 2 (04) 361-366 , discussion 371–372
• 7 GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388 (10053): 1545-1602
• 8 Adeloye D, Chua S, Lee C. et al; Global Health Epidemiology Reference Group (GHERG). Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health 2015; 5 (02) 020415
• 9 Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global Burden of Disease and Risk Factors. Washington: The World Bank; 2006
• 10 Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364 (9434): 613-620
• 11 Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007; 370 (9589): 786-796
• 12 Hurst JR, Vestbo J, Anzueto A. et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363 (12) 1128-1138
• 13 Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57 (10) 847-852
• 14 Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157 (5, Pt 1): 1418-1422
• 15 Peñuelas O, Muriel A, Abraira V. et al. Inter-country variability over time in the mortality of mechanically ventilated patients. Intensive Care Med 2020; 46 (03) 444-453
• 16 Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274 (23) 1852-1857
• 17 Alaithan AM, Memon JI, Rehmani RS, Qureshi AA, Salam A. Chronic obstructive pulmonary disease: hospital and intensive care unit outcomes in the Kingdom of Saudi Arabia. Int J Chron Obstruct Pulmon Dis 2012; 7: 819-823
• 18 Raurich JM, Pérez J, Ibáñez J, Roig S, Batle S. In-hospital and 2-year survival of patients treated with mechanical ventilation for acute exacerbation of COPD. Arch Bronconeumol 2004; 40 (07) 295-300
• 19 Breen D, Churches T, Hawker F, Torzillo PJ. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study. Thorax 2002; 57 (01) 29-33
• 20 Tobin MJ, Lodato RF. PEEP, auto-PEEP, and waterfalls. Chest 1989; 96 (03) 449-451
• 21 Smith TC, Marini JJ. Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. J Appl Physiol (1985) 1988; 65 (04) 1488-1499
• 22 Gay PC, Rodarte JR, Hubmayr RD. The effects of positive expiratory pressure on isovolume flow and dynamic hyperinflation in patients receiving mechanical ventilation. Am Rev Respir Dis 1989; 139 (03) 621-626
• 23 Stevenson NJ, Walker PP, Costello RW, Calverley PMA. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172 (12) 1510-1516
• 24 Squadrone E, Frigerio P, Fogliati C. et al. Noninvasive vs invasive ventilation in COPD patients with severe acute respiratory failure deemed to require ventilatory assistance. Intensive Care Med 2004; 30 (07) 1303-1310
• 25 Appendini L, Purro A, Patessio A. et al. Partitioning of inspiratory muscle workload and pressure assistance in ventilator-dependent COPD patients. Am J Respir Crit Care Med 1996; 154 (05) 1301-1309
• 26 Pepe PE, Marini JJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Respir Dis 1982; 126 (01) 166-170
• 27 Marini JJ. Lung mechanics determinations at the bedside: Instrumentation and clinical application. Respir Care 1990; 35 (07) 669-696
• 28 Rossi A, Ganassini A, Polese G, Grassi V. Pulmonary hyperinflation and ventilator-dependent patients. Eur Respir J 1997; 10 (07) 1663-1674
• 29 Purro A, Appendini L, De Gaetano A, Gudjonsdottir M, Donner CF, Rossi A. Physiologic determinants of ventilator dependence in long-term mechanically ventilated patients. Am J Respir Crit Care Med 2000; 161 (4, Pt 1): 1115-1123
• 30 Barberà JA, Roca J, Ferrer A. et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997; 10 (06) 1285-1291
• 31 Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364 (9435): 709-721
• 32 Vallverdú I, Calaf N, Subirana M, Net A, Benito S, Mancebo J. Clinical characteristics, respiratory functional parameters, and outcome of a two-hour T-piece trial in patients weaning from mechanical ventilation. Am J Respir Crit Care Med 1998; 158 (06) 1855-1862
• 33 Matić I, Danić D, Majerić-Kogler V, Jurjević M, Mirković I, Mrzljak Vucinić N. Chronic obstructive pulmonary disease and weaning of difficult-to-wean patients from mechanical ventilation: randomized prospective study. Croat Med J 2007; 48 (01) 51-58
• 34 Grasso S, Leone A, De Michele M. et al. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease. Crit Care Med 2007; 35 (01) 96-105
• 35 Matamis D, Tsagourias M, Papathanasiou A. et al. Targeting occult heart failure in intensive care unit patients with acute chronic obstructive pulmonary disease exacerbation: effect on outcome and quality of life. J Crit Care 2014; 29 (02) 315.e7-315.e14
• 36 MacDonald MI, Shafuddin E, King PT, Chang CL, Bardin PG, Hancox RJ. Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. Lancet Respir Med 2016; 4 (02) 138-148
• 37 Vitacca M, Vianello A, Colombo D. et al. Comparison of two methods for weaning patients with chronic obstructive pulmonary disease requiring mechanical ventilation for more than 15 days. Am J Respir Crit Care Med 2001; 164 (02) 225-230
• 38 Girault C, Daudenthun I, Chevron V, Tamion F, Leroy J, Bonmarchand G. Noninvasive ventilation as a systematic extubation and weaning technique in acute-on-chronic respiratory failure: a prospective, randomized controlled study. Am J Respir Crit Care Med 1999; 160 (01) 86-92
• 39 Girault C, Bubenheim M, Abroug F. et al; VENISE Trial Group. Noninvasive ventilation and weaning in patients with chronic hypercapnic respiratory failure: a randomized multicenter trial. Am J Respir Crit Care Med 2011; 184 (06) 672-679
• 40 Yeung J, Couper K, Ryan EG, Gates S, Hart N, Perkins GD. Non-invasive ventilation as a strategy for weaning from invasive mechanical ventilation: a systematic review and Bayesian meta-analysis. Intensive Care Med 2018; 44 (12) 2192-2204
• 41 Burns KE, Meade MO, Premji A, Adhikari NK. Noninvasive positive-pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev 2013; (12) CD004127
• 42 Ferrer M, Esquinas A, Arancibia F. et al. Noninvasive ventilation during persistent weaning failure: a randomized controlled trial. Am J Respir Crit Care Med 2003; 168 (01) 70-76
• 43 Prasad SB, Chaudhry D, Khanna R. Role of noninvasive ventilation in weaning from mechanical ventilation in patients of chronic obstructive pulmonary disease: an Indian experience. Indian J Crit Care Med 2009; 13 (04) 207-212
• 44 Schmidt M, Tachon G, Devilliers C. et al. Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults. Intensive Care Med 2013; 39 (05) 838-846
• 45 Abrams DC, Brenner K, Burkart KM. et al. Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2013; 10 (04) 307-314
• 46 Del Sorbo L, Pisani L, Filippini C. et al. Extracorporeal CO2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control. Crit Care Med 2015; 43 (01) 120-127
• 47 Kluge S, Braune SA, Engel M. et al. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med 2012; 38 (10) 1632-1639
• 48 Diehl JL, Piquilloud L, Richard JM, Mancebo J, Mercat A. Effects of extracorporeal carbon dioxide removal on work of breathing in patients with chronic obstructive pulmonary disease. Intensive Care Med 2016; 42 (05) 951-952
• 49 Taccone FS, Malfertheiner MV, Ferrari F. et al; EuroELSO Workgroup “Innovation on ECMO and ECLSx201D. Extracorporeal CO2 removal in critically ill patients: a systematic review. Minerva Anestesiol 2017; 83 (07) 762-772
• 50 Braune S, Sieweke A, Brettner F. et al. The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med 2016; 42 (09) 1437-1444
• 51 Barrett NA, Kostakou E, Hart N, Douiri A, Camporota L. Extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial. Trials 2019; 20 (01) 465
• 52 Evans T. International Consensus Conferences in intensive care medicine: noninvasive positive pressure ventilation in acute Respiratory failure. Intensive Care Med 2001; 163 (01) 283-291